Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
1.
J Dairy Sci ; 101(11): 10409-10413, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30172391

ABSTRACT

Our objective was to assess the ability of 3 herbal products to eliminate experimentally induced Streptococcus uberis mastitis. These herbal products, also known as phytoceuticals, are used in organically managed dairy cattle to maintain or promote udder health. The products tested were an intramammary product, a topical product, and a product applied to the vulvar area. These products are not approved by the US Food and Drug Administration for treatment of mastitis but they are sold to enhance milk quality or for maintenance or improvement of udder health. Each of the products contains at least one component shown to have antibacterial activity. In this study, we successfully challenge-inoculated 25 lactating dairy cows maintained under organic conditions with an isolate of S. uberis. All challenged cows were positive for S. uberis by milk culture after challenge. When cows met predefined criteria indicating the presence of clinical mastitis, treatment with 1 of the 3 products was initiated based upon a predetermined random allocation. Culture of aseptically collected quarter milk samples was performed before, during, and following challenge with S. uberis. Eight, 8, and 9 cows received the intravulvar, intramammary, and topical treatments, respectively. Milk from all cows that were treated with phytoceuticals were culture-positive for S. uberis at every time point following treatment through 168 h following the last phytoceutical treatment. Based upon the presence of clinical signs and for humane reasons, 2 intravulvar-treated cows, 1 topical-treated, and 4 intramammary-treated cows received intramammary antibiotic therapy. We concluded that the phytoceuticals tested, as dosed and used in this trial, did not produce bacterial cures in S. uberis-induced mastitis.


Subject(s)
Anti-Bacterial Agents/pharmacology , Mastitis, Bovine/drug therapy , Milk/drug effects , Plant Preparations/pharmacology , Streptococcal Infections/veterinary , Streptococcus/drug effects , Animals , Cattle , Female , Lactation , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/microbiology , Mastitis, Bovine/microbiology , Milk/microbiology , Random Allocation , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology
2.
J Dairy Sci ; 97(9): 5587-91, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25022682

ABSTRACT

Nonantibiotic treatments for mastitis are needed in organic dairy herds. Plant-derived oils may be useful but efficacy and potential mechanisms of action of such oils in mastitis therapy have not been well documented. The objective of the current study was to evaluate the antibacterial activity of the plant-derived oil components of Phyto-Mast (Bovinity Health LLC, Narvon, PA), an herbal intramammary product, against 3 mastitis-causing pathogens: Staphylococcus aureus, Staphylococcus chromogenes, and Streptococcus uberis. Plant-derived oils evaluated were Thymus vulgaris (thyme), Gaultheria procumbens (wintergreen), Glycyrrhiza uralensis (Chinese licorice), Angelica sinensis, and Angelica dahurica. Broth dilution testing according to standard protocol was performed using ultrapasteurized whole milk instead of broth. Controls included milk only (negative control), milk + bacteria (positive control), and milk + bacteria + penicillin-streptomycin (antibiotic control, at 1 and 5% concentrations). Essential oil of thyme was tested by itself and not in combination with other oils because of its known antibacterial activity. The other plant-derived oils were tested alone and in combination for a total of 15 treatments, each replicated 3 times and tested at 0.5, 1, 2, and 4% to simulate concentrations potentially achievable in the milk within the pre-dry-off udder quarter. Thyme oil at concentrations ≥2% completely inhibited bacterial growth in all replications. Other plant-derived oils tested alone or in various combinations were not consistently antibacterial and did not show typical dose-response effects. Only thyme essential oil had consistent antibacterial activity against the 3 mastitis-causing organisms tested in vitro. Further evaluation of physiological effects of thyme oil in various preparations on mammary tissue is recommended to determine potential suitability for mastitis therapy.


Subject(s)
Anti-Bacterial Agents/pharmacology , Plant Oils/pharmacology , Animals , Cattle , Female , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/microbiology , Mastitis, Bovine/drug therapy , Mastitis, Bovine/microbiology , Milk/microbiology , Oils, Volatile/pharmacology , Staphylococcus/drug effects , Staphylococcus aureus/drug effects , Streptococcus/drug effects , Thymus Plant/chemistry
3.
J Dairy Sci ; 96(10): 6753-62, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23932134

ABSTRACT

The organic dairy industry is growing rapidly across the United States and has recently expanded into the southeastern states. To date, no published comparisons of milk quality exist between organic and conventional dairies in the Southeastern United States. Maintaining high milk quality is challenging in this region due to the longer periods of high heat and humidity. The objective of this observational study was to compare milk quality on organic and conventional dairies in North Carolina during the warm summer months of the year. Data were compared from 7 organically and 7 conventionally managed herds in North Carolina. To assess milk quality, milk samples were aseptically collected from each functional quarter of each cow in the milking herds at the time of sampling and linear somatic cell scores (SCS) were obtained for individual cows. A total of 4,793 quarter milk samples (2,526 conventional and 2,267 organic) were collected from 1,247 cows (652 conventional and 595 organic). Milk samples were cultured and bacterial growth was identified using protocols consistent with those of the National Mastitis Council (Verona, WI). Subclinical mastitis was defined as the presence of SCS ≥ 4 and also a microbiological infection in at least 1 quarter. The proportion of cows with subclinical mastitis did not differ between conventional (20.8%) and organic (23.3%) herds. No significant difference was observed between herd management types in the proportion of cows without microbiological growth in milk samples. Also, no significant differences were observed between organic and conventional herds for cow-level prevalence of Staphylococcus aureus, coagulase-negative Staphylococcus spp., Streptococcus spp., or Corynebacterium spp. Two of the organic herds had a notably higher prevalence of Corynebacterium spp. and higher SCS. Coliforms were found in 5 of 7 conventional herds and in only 1 of 7 organic herds. Mean SCS did not differ between conventional (3.3±0.2) and organic (3.5±0.2) herds. Despite differences in herd management, milk quality was remarkably similar between the organic and conventional dairies compared for this study.


Subject(s)
Dairying/standards , Food Contamination/statistics & numerical data , Food Quality , Food, Organic/microbiology , Mastitis, Bovine/epidemiology , Milk/microbiology , Animals , Cattle , Corynebacterium/isolation & purification , Female , Mastitis, Bovine/microbiology , Mastitis, Bovine/transmission , North Carolina , Prevalence , Seasons , Staphylococcus/isolation & purification , Staphylococcus aureus/isolation & purification , Streptococcus/isolation & purification
4.
J Dairy Sci ; 89(12): 4551-6, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17106086

ABSTRACT

Pulsed-field gel electrophoresis (PFGE) after SmaI digestion was used to investigate the persistence of specific genotypes of bovine mammary gland isolates of Staphylococcus aureus on 3 dairy herds. A total of 341 isolates of Staph. aureus were available from cows in 3 herds, collected over a period of 15 yr. Pulsed-field gel electrophoresis band patterns of Staph. aureus isolates were analyzed visually and with gel analysis and comparison software. Based on this analysis, isolates were classified by PFGE type. Persistence was determined as the time period from the first to the last isolation of a particular PFGE type of Staph. aureus within a herd. Specific types of mastitis-causing Staph. aureus persisted long-term on these dairies. For example, PFGE type 3 isolates persisted on farms A, B, and C for 15, 15, and 13 yr, respectively. Type 6 was found to persist for 13 yr on farm C. Despite the application of standard mastitis control practices, mastitis-causing Staph. aureus types appeared to persist long-term, as detected by PFGE, and were isolated coincident with herd problems of increased milk somatic cell counts and decreased milk production.


Subject(s)
Mastitis, Bovine/microbiology , Milk/microbiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/genetics , Animals , Cattle , Dairying , Deoxyribonucleases, Type II Site-Specific , Electrophoresis, Gel, Pulsed-Field/veterinary , Female , Genotype , Phylogeny , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/physiology , Time Factors
5.
J Dairy Sci ; 88(2): 466-9, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15653510

ABSTRACT

Milk antibiotic residues have been a public concern in recent years. The Grade A Pasteurized Milk Ordinance mandates that raw Grade A milk will test negative for beta-lactam antibiotic residues before processing. The purpose of this research was to investigate the ability of various levels of peroxide and heat to inactivate penicillin G in raw milk. Whole milk spiked to a mean of 436 +/- 15.1 (standard error of the mean) ppb of potassium penicillin G was treated with hydrogen peroxide at levels of 0.0, 0.09, 0.17, and 0.34%. Samples at each peroxide level (n = 6 per treatment) were treated as follows: 1) incubated at 54.4 degrees C for 3 h, 2) pasteurized at 62.8 degrees C for 30 min, 3) incubated and pasteurized as in treatments 1 and 2, or 4) received no further treatment. A beta-lactam competitive microbial receptor assay was used for quantification of penicillin G. Concentrations of penicillin in selected samples were determined by HPLC for a comparison of test methods. Treatments were evaluated relative to their ability to reduce milk penicillin G levels to below the safe level of 5 ppb. The 0.09% hydrogen peroxide level was ineffective for all treatments. Hydrogen peroxide at 0.17% lowered the mean penicillin G (+/- SEM) from 436 +/- 15.1 to 6 +/- 1.49 ppb using the incubated and pasteurized heat treatment. The 0.34% concentration of hydrogen peroxide was the most effective, inactivating penicillin G to a level well below the safe level of 5 ppb with the pasteurized heat treatment, with or without incubation.


Subject(s)
Drug Residues/analysis , Hot Temperature , Hydrogen Peroxide/pharmacology , Milk/chemistry , Penicillin G/antagonists & inhibitors , Animals , Food Handling/methods , Hydrogen Peroxide/administration & dosage , Penicillin G/analysis
7.
J Nutr ; 107(2): 281-8, 1977 Feb.
Article in English | MEDLINE | ID: mdl-833689

ABSTRACT

Pancreatic enzyme output in response to various purified diets was studied in rats surgically prepared so that pancreatic secretion could be continuously collected, assayed and returned to the intestine. Intraduodenal infusion of phenylalanine and tryptophan alone did not stimulate secretion. Diets containing phenylalanine, tryptophan, a mixture of amino acids, or hydroxyzed casein, fed intragastrically, evoked a small pancreatic response that was similar to the response to a protein-free diet. intragastric infusion of a diet containing 18% casein stimulated a large initial secretion of enzyme that remained elevated throughout the 5.5 hour experiment. Addition of soybean trypsin inhibitor (SBTI) to the diet increased the pancreatic response over that due to dietary casein alone. When pancreatic juice was diverted from the intestine, the large pancreatic responses to casein or to casein + SBTI were greatly reduced and the response was similar to that of the protein-free diet.


Subject(s)
Amino Acids/metabolism , Caseins/metabolism , Pancreas/metabolism , Trypsin Inhibitor, Kunitz Soybean/pharmacology , Trypsin Inhibitors/pharmacology , Animals , Dietary Proteins/metabolism , Intestinal Mucosa/metabolism , Male , Pancreatic Juice/metabolism , Phenylalanine/metabolism , Proteins/metabolism , Rats , Tryptophan/metabolism
10.
Lipids ; 11(3): 194-202, 1976 Mar.
Article in English | MEDLINE | ID: mdl-1263762

ABSTRACT

14C1-Linolenic acid was incorporated into lipids of hearts, livers, and carcasses of male rats. We studied the influence of diet composition on extent and distribution of radioactivity. A CHOW diet, a purified, essential fatty acid (EFA)-deficient diet, a purified control diet, and EFA-deficient diets with four fatty acid supplements were used. Supplements of 18:2n-6, 20:4n-6, 15:3n-3, and 22:6n-3 were given as single doses. Radioactivities in liver phosphatidyl ethanolamines (PE), phosphatidyl cholines, and neutral lipids were measured. The distribution of radioactivity among the fatty acids in liver phospholipids was determined. Rats on CHOW diet incorporated far less radioactivity than any other group into lipids of hearts and livers. Most of the activity in livers was recovered as 20:5n-3 and 22:6n-3 in all rats. In EFA-deficient rats, the radioactivity in 22:6n-3 of liver PE was still increasing 36 hr after 14C1-linolenic acid had been administered. The n-6 supplements (18:2n-6 and 20:4n-6) seemed to reduce the coversion of 20:4n-3 to 20:5n-3 (desaturation), whereas the n-3 supplements (18:3n-3 and 22:6n-3) reduced the conversion of 20:5n-3 to 22:5n-3 (elongation). Formation of 22:6n-3 may be controlled by 22:6n-3 itself at the elongation of 20:5n-3 to 22:5n-3.


Subject(s)
Dietary Fats , Fatty Acids, Unsaturated/biosynthesis , Linolenic Acids/metabolism , Animals , Chromatography, Gas , Liver/metabolism , Male , Muscles/metabolism , Myocardium/metabolism , Organ Specificity , Phosphatidylcholines/biosynthesis , Rats
11.
Proc Soc Exp Biol Med ; 148(3): 897-903, 1975 Mar.
Article in English | MEDLINE | ID: mdl-1168919

ABSTRACT

Further studies on the feedback regulation of pancreatic enzyme secretion by trypsin were conducted in conscious rats, surgically prepared so that pancreatic juice could be collected or returned. Suppression of enzyme secretion by trypsin as well as its stimulation by SBTI occurred only in the upper part of the small intestine, where the hormone CCK is known to be released. Over a limited range, trypsin suppression of pancreatic secretion was proportional to the dose of trypsin. Higher concentrations had no further effect, suggesting "saturation" of the intestine. Trypsin which had its active center blocked by DFP did not suppress enzyme output. These results supported the concept that only trypsin (or chymotrypsin) with an exposed active center suppressed pancreatic enzyme secretion in the rat by somehow suppressing the release of CCK from the intestinal cell. Presumably CCK is released from the intestine following "removal" of trypsin from the intestine either by diverting the juice or by feeding SBTI which binds the enzyme. All of the evidence supported the view that the effect of trypsin or SBTI on pancreatic secretion was mediated at the intestinal level and not in the blood as has been suggested.


Subject(s)
Feedback , Intestines/physiology , Pancreas/enzymology , Animals , Cattle , Cholecystokinin/metabolism , Cholecystokinin/pharmacology , Chymotrypsin/pharmacology , Depression, Chemical , Intestine, Small/enzymology , Intestine, Small/physiology , Intestines/enzymology , Isoflurophate/pharmacology , Male , Pancreas/metabolism , Pancreatic Juice/enzymology , Pancreatic Juice/metabolism , Rats , Sodium Chloride/pharmacology , Glycine max , Stimulation, Chemical , Trypsin/administration & dosage , Trypsin/pharmacology , Trypsin Inhibitors/pharmacology
12.
Lipids ; 10(3): 157-67, 1975 Mar.
Article in English | MEDLINE | ID: mdl-1128170

ABSTRACT

To see how the metabolism of specific phosphatidyl choline fractions might be affected when only a limited source of methyl groups was available, rats were fed for 7 days a low methionine, choline-deficient diet or one supplemented with either choline or methionine. Prior to killing, they were injected with -14C-methyl methionine and liver and plasma phosphatidyl choline isolated and separated by argentation chromatography into 3 major unsaturated fractions. Fatty acid composition and radioactivity of the fractions were determined. Deficient rats had reduced total liver phosphatidyl choline when compared with the supplemented groups, but the proportions of 20:4 and 22:6 fatty acids in the total phosphatidyl choline were unchanged. Plasma phosphatidyl choline also was reduced sharply by the deficiency, as was its proportion of 20:4 fatty acid. Specific activities of the liver 22:6, 20:4, and 18:2 phosphatidyl choline fractions showed that deficient rats had less radioactivity in their 20:4 and 18:2 phosphatidyl choline than did the supplemented animals. Plasma phosphatidyl choline fractions presented a similar pattern. Feeding methionine or choline nearly doubled radioactive methyl group incorporation into the 20:4 phosphatidyl choline fraction of liver and plasma, while incorporation into the 22:6 phosphatidyl choline was reduced or unchanged. The results suggested that, in the rat, limited availability of methyl groups altered the metabolism of liver and plasma phosphatidyl choline fractions. Methionine, as a source of labile methyl groups, appears necessary for the normal synthesis of certain unsaturated phosphatidyl choline fractions (particularly 20:4 phosphatidyl choline). Transmethylation of phosphatidyl ethanolamine molecular species to the corresponding phosphatidyl choline species may be an important reaction in normal lipid metabolism and transport. Relative affinities for incorporation of the labeled methyl groups into the phosphatidyl choline fractions of either deficient or supplemented rats were: 22:6 less than 20:4 less than 18:2.


Subject(s)
Choline Deficiency/metabolism , Liver/metabolism , Methionine/pharmacology , Phosphatidylcholines/metabolism , Animals , Choline/pharmacology , Chromatography, Thin Layer , Diet , Liver/drug effects , Male , Phosphatidylcholines/blood , Rats , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...